The characterization of chemokine production and chemokine receptor expression reveals possible functional cross-talks in AML blasts with monocytic differentiation

Experimental Hematology

Volumn 31, Issue 6, 2003, Pages 495-503

  Cignetti, Alessandro ^b,d   Vallario, Antonella ^a,d   Roato, Ilaria ^a,d   Circosta, Paola ^a,d   Strola, Giuliana ^d   Scielzo, Cristina ^d   Allione, Bernardino ^c   Garetto, Lucia ^d   Caligaris Cappio, Federico ^a,b,d   Ghia, Paolo ^a,b,d  

^a UNIVERSITY OF TURIN   (Italy)

^b MAURIZIANO HOSPITAL   (Italy)

^c C Arrigo Children's Hospital   (Italy)

^d CANDIOLO CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; RANTES; STROMAL CELL DERIVED FACTOR 1ALPHA; STROMAL CELL DERIVED FACTOR 1BETA; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; CELL ACTIVATION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURFACE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MONOCYTE; MYELOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; SUPERNATANT; VALIDATION PROCESS;

EID: 0038387795     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(03)00066-3     Document Type: Conference Paper

References (30)

1. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol. 55:1994;97-179.
2. Kunz M., Hartmann A., Flory E., et al. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am J Pathol. 155:1999;753-763.
3. Neumark E., Anavi R., Witz I.P., Ben-Baruch A. MCP-1 expression as a potential contributor to the high malignancy phenotype of murine mammary adenocarcinoma cells. Immunol Lett. 68:1999;141-146.
4. Murphy P.M., Baggiolini M., Charo I.F., et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors . Pharmacol Rev. 52:2000;145-176.
5. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol. 18:2000;217-242.
6. Tobler A., Moser B., Dewald B., et al. Constitutive expression of interleukin-8 and its receptor in human myeloid and lymphoid leukemia. Blood. 82:1993;2517-2525.
7. Vinante F., Rigo A., Vincenzi C., et al. IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells. Leukemia. 7:1993;1552-1556.
8. Legdeur M.C., Beelen R.H., Schuurhuis G.J., et al. A functional study on the migration of human monocytes to human leukemic cell lines and the role of monocyte chemoattractant protein-1. Leukemia. 11:1997;1904-1908.
9. Legdeur M.C., Broekhoven M.G., Schuurhuis G.J., Beelen R.H., Ossenkoppele G.J. Monocyte-chemoattractant-protein-1-mediated migration of human monocytes towards blasts from patients with acute myeloid leukemia. Cancer Immunol Immunother. 50:2001;16-22.
10. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood. 91:1998;4523-4530.
11. Mohle R., Schittenhelm M., Failenschmid C., et al. Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia. Br J Haematol. 110:2000;563-572.
12. Brouwer R.E., Hoefnagel J., van Der Burg B.B., et al. Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis. Br J Haematol. 115:2001;298-308.
13. Voermans C., van Heese W.P., de Jong I., Gerritsen W.R., van Der Schoot C.E. Migratory behavior of leukemic cells from acute myeloid leukemia patients. Leukemia. 16:2002;650-657.
14. + cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus. Blood. 94:1999;62-73.
15. + cells and megakaryoblasts secrete β-chemokines that block infection of hematopoietic cells by M-tropic R5 HIV. J Clin Invest. 104:1999;1739-1749.
16. Sarris A.H., Talpaz M., Deisseroth A.B., Estrov Z. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors. Leukemia. 10:1996;757-765.
17. Basara N., Stosic-Grujicic S., Sefer D., Ivanovic Z., Antunovic P., Milenkovic P. The inhibitory effect of human macrophage inflammatory protein-1 α (LD78) on acute myeloid leukemia cells in vitro. Stem Cells. 14:1996;445-451.
18. Ferrajoli A., Talpaz M., Zipf T.F., et al. Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-α Leukemia. 8:1994;798-805.
19. Owen-Lynch P.J., Adams J.A., Brereton M.L., Czaplewski L.G., Whetton A.D., Yin J.A. The effect of the chemokine rhMIP-1 α, and a nonaggregating variant BB-10010, on blast cells from patients with acute myeloid leukaemia. Br J Haematol. 95:1996;77-84.
20. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 103:1985;620-625.
21. Stelzer G.T., Shults K.E., Loken M.R. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann N Y Acad Sci. 677:1993;265-280.
22. Jennings C.D., Foon K.A. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood. 90:1997;2863-2892.
23. Andrew D.P., Ruffing N., Kim C.H., et al. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J Immunol. 166:2001;103-111.
24. Zabel B.A., Agace W.W., Campbell J.J., et al. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J Exp Med. 190:1999;1241-1256.
25. Ghia P., Transidico P., Veiga J.P., et al. Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells. Blood. 98:2001;533-540.
26. Schaniel C., Pardali E., Sallusto F., et al. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J Exp Med. 188:1998;451-463.
27. Broxmeyer H.E., Youn B.S., Kim C., Hangoc G., Cooper S., Mantel C. Chemokine regulation of hematopoiesis and the involvement of pertussis toxin-sensitive G α i proteins. Ann N Y Acad Sci. 938:2001;117-127. discussion 127-128.
28. Nagai M., Masuzawa T. Vaccination with MCP-1 cDNA transfectant on human malignant glioma in nude mice induces migration of monocytes and NK cells to the tumor. Int Immunopharmacol. 1:2001;657-664.
29. Liss C., Fekete M.J., Hasina R., Lam C.D., Lingen M.W. Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages. Int J Cancer. 93:2001;781-785.
30. Kleeff J., Kusama T., Rossi D.L., et al. Detection and localization ofMip-3α/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer. 81:1999;650-657.